Conavi Medical Corp.
CNVI.V
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.94M | -4.93M | -2.57M | -- | -5.03M |
| Total Depreciation and Amortization | 124.80K | 132.90K | 133.70K | -- | 148.60K |
| Total Amortization of Deferred Charges | 8.60K | 12.30K | 13.00K | -- | -- |
| Total Other Non-Cash Items | -1.69M | 1.64M | -618.70K | -- | -503.60K |
| Change in Net Operating Assets | 451.90K | -467.60K | -2.56M | -- | -847.20K |
| Cash from Operations | -3.04M | -3.62M | -5.61M | -- | -6.23M |
| Capital Expenditure | -21.50K | -8.00K | -4.30K | -- | -20.70K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -82.50K | -64.60K | 0.00 | -- | 2.67M |
| Cash from Investing | -104.00K | -72.60K | -4.30K | -- | 2.65M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -485.00K | -301.00K | -428.00K | -- | -430.00K |
| Issuance of Common Stock | -- | -- | 12.11M | -- | 10.09M |
| Repurchase of Common Stock | -- | -40.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -22.00K | 6.33M | -- | -- |
| Cash from Financing | -347.90K | -263.60K | 13.02M | -- | 6.90M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.49M | -3.95M | 7.41M | -- | 3.32M |